The Power of First-in-Human Trials: A Glimpse into Zelenirstat’s Impact on Mesothelioma
The journey towards a breakthrough cancer treatment often begins with groundbreaking trials. Zelenirstat is a cutting-edge drug currently under study.…
Unlocking Mesothelioma’s Secrets: Understanding the Tumor Microenvironment
Researchers are working hard to understand the area around mesothelioma tumors. This is known as the tumor microenvironment. The tumor…
Decoding Pleural Mesothelioma: Insights from a Ten-Year Study
Recently, a group of researchers studied 169 patients with pleural mesothelioma over ten years. They wanted to gain a deeper…
Discovering the Link to Mesothelioma Growth
Italian researchers have found that a molecule called cycle adenosine monophosphate (cAMP) is involved in the growth of mesothelioma. cAMP…
Electronic Health Record Supports Malignant Pleural Mesothelioma Research
A new method of research is becoming more popular in the study of malignant pleural mesothelioma. Most doctors use an…
Second Treatment Course May Increase Mesothelioma Patient Survival
Oncologists report that a second treatment course may be a good option for some mesothelioma patients. Almost all mesothelioma patients…
Nanoparticles May Offer New Treatment for Peritoneal Mesothelioma
American scientists may have found a new way to fight mesothelioma and other cancers from the inside out by targeting…
Drug Combo Nivolumab plus ipilimumab Has Best Survival Rates in Relapsed Mesothelioma
Malignant pleural mesothelioma is an aggressive cancer with limited therapeutic options. Pemetrexed plus platinum is often the first treatment option…
A Multimodality Treatment Plan may be Best for Pleural Mesothelioma
A multimodality treatment plan may improve mesothelioma patient outcomes. Malignant pleural mesothelioma is an invasive, locally aggressive tumor related to…
Asia | International | New Studies | Prevention | Research
Could Phlebotomy Delay Development of Mesothelioma?
New research from Japan suggests that removing some blood from the body might offer a way to delay the development…